| For: | Yao ZY, Liu J, Ma X, Li WT, Shen Y, Cui YZ, Fang Y, Han ZX, Yang CH. Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy. World J Gastrointest Oncol 2025; 17(6): 107980 [PMID: 40547166 DOI: 10.4251/wjgo.v17.i6.107980] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i6/107980.htm |
| Number | Citing Articles |
| 1 |
Xin Zheng, Jing Chen, Meng-Ting Li. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and systemic immune-inflammation index predict survival in HER2-negative advanced gastric cancer. World Journal of Gastrointestinal Oncology 2026; 18(9): 124094 doi: 10.4251/wjgo.124094
|
| 2 |
Jingyi Zhou, Jingzhi Wang, Lin Liu. Exposure–response relationship of sintilimab in advanced gastric cancer: insights from time-dependent pharmacokinetics and biomarker integration for precision immunotherapy. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1875485
|
| 3 |
Yanchen Nie, Zongxin Zhang, Zhenghai Wu. Prognostic and clinicopathological role of fibrinogen-to-albumin ratio in biliary tract cancers: a meta-analysis. Biomarkers in Medicine 2026; 20(8-9) doi: 10.1080/17520363.2026.2691461
|